4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001995218-25-000007
Chief Executive Officer sold 1,127 shares at $9.27 ($10,447)
From the SEC's structured data for this filing
Trades in this filing
Townsend Richard Nolan · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-18 | Sale : show line 1 in the form | −1,127 | $9.27 | $10,447 | 240,991 | D |
| Open-market sales · 1,127 sh · avg $9.27 · $10,447 | ||||||
Loading xslF345X05/form4-11202025_101125.xml…